cms_DC: 93
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 93 |
SERENITY REHABILITATION AND HEALTH CENTER LLC |
95015 |
1380 SOUTHERN AVE SE |
WASHINGTON |
DC |
20032 |
2016-08-18 |
386 |
D |
0 |
1 |
GZ9J11 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and staff interview for one (1) of 35 Stage 2 sampled residents , it was determined that the physician failed to follow through on one (1) resident ' s diagnostic test. Resident #45. The findings include: An interim physician's order dated (MONTH) 4, (YEAR) at 12:20 PM directed: Psychiatry- F/U (Follow-up) for Resident ' s [MEDICATION NAME] (secondary to) elevated prolactin level (hormone level made by the pituary gland)- 38.23 (high); ( normal range-1.8-20.3) done on 12/21/15. A review of the clinical record revealed: Report of Consultation (not dated), From: (Attending physician named), Report requested regarding: Psychiatry (follow-up) for resident ' s [MEDICATION NAME] use secondary to elevated prolactin level 38.23 (1.8-20.3) done on 12/21/15; Report: Findings: Will see today 1/11/16 . (psychiatry signature) . A review of the psychiatry notes revealed the following: December 28, (YEAR)- . Axis I- [MEDICAL CONDITION] -[MEDICATION NAME] 150mg po bid for mood stabilization, Follow up in 2 weeks January 19, (YEAR)- .Axis I: [MEDICAL CONDITION]- Continue current treatment, Follow up in (a) month March 28, (YEAR)- . Axis I: [MEDICAL CONDITION]- Continue current treatment, Follow up in a month June 13, (YEAR) . Axis I: [MEDICAL CONDITION], continue current treatment, Follow up in one month . A review of the attending physician ' s notes from (MONTH) (YEAR) to (MONTH) (YEAR) revealed no documentation regarding the resident ' s elevated prolactin level. There was no evidence in the clinical record that the attending and psychiatric physician followed up to review the status of the elevated prolactin level. A face-to-face interview was conducted with Employees #5 and #19 on (MONTH) 17, (YEAR) at approximately 11:20 AM regarding the aforementioned findings. Both acknowledged the findings. Employee #19 stated he/she will follow-up. The clinical record was reviewed on (MONTH) 17, (YEAR). |
2020-09-01 |